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Leishmaniasis has reemerged in recent years showing a wider geographic distribution and increased global incidence of human and
canine disease than previously known. Dogs are the main domestic/peridomestic reservoir hosts of zoonotic visceral leishmaniasis
caused by Leishmania infantum. Since the evolution of leishmaniasis and clinical appearance is a consequence of complex
interactions between the parasite and host immune response, a profound knowledge about the immune profile developed in
dog’s infection is crucial for vaccine and immunomodulatory therapy design. The main goal of this paper is to compile the recent
advances made on cytokine and phenotypic cell profiles in different tissues and organs of dogs infected with L. infantum. This
paper also stressed that the knowledge of the immune responses developed, namely, in liver, lymph node, and spleen is very
limited. All data emphasizes that more research on canine leishmaniasis is necessary for the development of new and efficacious
tools to control zoonotic leishmaniasis.
1. Introduction
Canine leishmaniasis (CanL) caused by Leishmania infantum
(syn. L. chagasi, in Latin America), which is transmitted
by the bite of phlebotomine sand flies, is endemic and
affects millions of dogs in the Mediterranean basin, China,
and Latin America and is an emergent disease in North
America. Dogs are described as the best experimental animal
model for visceral leishmaniasis caused by L. infantum,
because many of the clinicopathological signs and immune
responses observed in experimental CanL are similar to
those observed on natural canine and human Leishmania
infection [1, 2]. It has been claimed that dogs never achieve
parasitological cure, and the widespread use of the available
anti-Leishmania drugs for both canine and human treatment
may contribute to parasite drug resistance. Therefore, an
efficacious CanL vaccine able to block parasite transmission
would be the best strategy to control the spread of the disease
among other dogs and an essential part for the control
of human zoonotic leishmaniasis [3]. The development of
efficient immunoprophylactic molecules to maintain long-
term immunity and to promote leishmaniases control relies
on the identification and the characterization of the immune
events associated with disease progression.
Clinical appearance and evolution of leishmaniasis is a
consequence of complex interactions between the parasite
and the genetic and immunological background of the host.
It is widely accepted that in susceptible animals the progres-
sion of infection to active disease is characterized by a marked
humoral response, a cellular immune depression against
the parasite, and the appearance of a full array of clinical
signs. On the other hand, resistant dogs lack clinical signs,
develop low levels of anti-Leishmania antibodies and parasite
load, and develop a strong in vitro lymphocyte proliferative
response and a positive delayed-type hypersensitive response
to leishmanial antigens in the skin [4–6]. Nevertheless, it is
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important to keep in mind that animals considered resistant
could be in an earlier stage of disease prior to developing
signs of susceptibility [7].
Determining the role of T-helper-1 (Th1) and Th2 lym-
phocyte subpopulations in different tissues and organs
of infected dogs is crucial to understand the immune
mechanisms induced by infection. Previous studies described
that cellular immune response in CanL was associated with
activation of Th1 cells producing interferon-gamma (IFN-
γ), interleukin-2 (IL-2), and tumour necrosis factor alpha
(TNF-α) while cytokine pattern of active disease was char-
acterized by a mixed Th1/Th2 response [5]. However, most
of these works were made on peripheral blood (PB). Fur-
thermore, other studies showed that the immune response to
the parasite is not identical in whole host system but instead
organ-specific [8]. In fact, a Th1, Th2, or mixed Th1/Th2
immune responses were observed in different organs of dogs
infected with L. infantum and correlated with the presence or
the absence of clinical signs and local parasite load [7, 9–12].
The organ-specific and mixed Th1/Th2 immune responses
were also verified in leishmaniasis murine model [13, 14].
The challenges regarding local and systemic immune
responses to the parasites need to be answered to achieve
the development of efficacious strategies to control canine
and human visceral leishmaniasis. The aim of this paper
was to describe the recent studies about the cytokine
and cell population profiles developed in different target
organs/tissues, namely, bone marrow, lymph node, liver,
peripheral blood, skin, and spleen developed by the dog to
L. infantum infection.
2. Tissue and Organ Immune Responses in
Canine Leishmaniasis
2.1. Peripheral Blood. IFN-γ expression or production by
nonstimulated peripheral blood mononuclear cell (PBMC)
lymphocytes or stimulated with soluble Leishmania antigen
(SLA) from infected dogs has been correlated with disease
resistance/asymptomatic status in both nonvaccinated and
vaccinated animals [15, 16] as well as in dogs challenged with
uninfected or infected colony reared Lutzomyia longipalpis
[17]. Taking into account the results obtained in those
works, the no expression of IFN-γ by PB (Table 1) could
have been related with the persistence of infection in an
experimental canine study performed in our laboratory [6].
On the other hand, Travi et al. [11] observed that the
PMBC stimulated with SLA from 67% of symptomatic dogs
experimentally infected with promastigotes isolated from
the vector Lutzomyia longipalpis produced high levels of
IFN-γ at the early stages of infection, and the proportion
of individuals producing this cytokine increased over time,
indicating that IFN-γ production and expression was not
sufficient to prevent disease and, consequently, was not a
good marker of resistance. On opposite, Carrillo et al. [16]
found a depleted expression of IFN-γ in response to SLA
in symptomatic experimentally infected dogs; according to
Carrillo and Moreno [5], the low expression of this cytokine
might have been associated with a diminished CD4+ T
Table 1: Frequencies of cytokine and iNOS expressions determined
by reverse transcriptase PCR in 12 asymptomatic dogs (with high












Peripheral blood 0 91.66 66.66 0 0
Lymph node 0 36.36 54.54 81.81 36.36
Liver 9 18.16 0 18.19 18.19
spleen 11.11 11.11 0 33.33 33.33
Bone marrow 25 66.66 41.66 100 75
INF-γ: interferon-gamma; TGF-β: transforming growth factor-beta; TNF-α:
tumour necrosis factor-alpha; IL-10: interleukin-10; iNOS: inducible nitric
oxide synthetase.
lymphocyte subset population. Several studies analysing
lymphocyte subtypes by flow cytometry have pointed out
that this PB population in sick dogs is decreased but
returns to normal values after treatment [18–20], others
observed an increased number of CD4+ cells in dogs with
low parasitism [21]. Furthermore, others found out that
the number of CD4+ T-cells in PB was similar in dogs
with leishmaniasis and in healthy dogs and that there
was no correlation between the clinical status or response
to therapy and CD4+ counts [22, 23]. The contradictory
results obtained highlights the complexity of the immune
response mounted in response to L. infantum infection
and that this lymphocyte subtype cannot be used alone as
a prognosis marker. Reduction in CD3+ and increased CD5+
lymphocyte subpopulations in PB has been described in
symptomatic dogs [18, 21, 23] while high CD8+ numbers
were detected in animals with low parasitism [19, 21].
It was observed that a decreased CD21+ B cells, CD14+
monocytes, and class II molecules of the major histocom-
patibility complex (MHC-II) in symptomatic dogs were
related with selective migration into lymphoid organs and
lower ability for antigen presentation [21]. The contradictory
results obtained were probably due to the comparison of
the blood leukocyte subpopulations and parasite loads in
different compartments. Moreover, the differences obtained
between studies could also be related with the classification
of the animals not only with the absence or presence of
clinical signs but also with the development of specific anti-
Leishmania antibodies or the detection of parasite since each
methodology presents different sensitivity and specificity.
Regarding the expression and/or production of other
cytokines in peripheral blood, results are also discrepant.
While for some authors interleukin-6 (IL-6) [24] and IL-18
[25] are markers of active disease or asymptomatic infection;
respectively, for others IL-6 [26] and IL-18 [15, 16] have no
determinant role. Similar results were obtained for IL4 and
IL10, where their expression was only observed in mitogen-
stimulated PBMC from symptomatic dogs [27] while others
detected it in animals presenting clinical signs or not [15, 16].
From these studies, IL-4 did not seem to contribute to canine
susceptibility to infection. On the other hand, the increase
of IL-10 production by PBMC stimulated with SLA along
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with increase blood parasite burden has recently pointed
out to be predictive of the evolution of canine infection
[7]. Others have verified the association between IL-10 and
active visceral leishmaniasis in humans [28]. Nonetheless,
the spectrum of cytokines and the immunophenotypic of
cells cannot be considered good markers to predict the
evolution of infection since PB is not the tissue of election
for parasite multiplication and persistence.
2.2. Skin. Skin is essential for the transmission of Leishmania
since it is the tissue where an infected sand fly inoculates
parasites into the vertebrate and the first barrier of the
immune system. In the study performed by Solano-Gallego
et al. [29], muzzle skin of asymptomatic dogs had no
histological demonstration of lesions neither amastigotes,
but parasitesDNA was detected. According to these authors,
asymptomatic dogs found positive to Leishmania parasites
by PCR do not play a significant role in the infection
of phlebotomine sand flies. However, in a recent work
performed by Madeira et al. [30], L. chagasi was isolated
from intact skin from different body regions of 292 out
of 394 seropositive dogs despite that only 21.9% of them
were recognised as symptomatic. Furthermore, Guarga et al.
[31] through xenodiagnosis concluded that asymptomatic
dogs were infectious to the sand fly vectors. All these data
suggest that parasites have large distribution in the skin
of infected dogs in spite of remaining asymptomatic for
prolonged time and for that reason not submitted to any
control measures. The presence of parasites in these animals
highlights their importance as reservoir hosts. Thus, from
an epidemiological point of view, it would be important to
correlate the local immune response of skin to the presence
of the parasite as well as with the infectiousness to competent
vectors and therefore, allow the development of tools for
blocking transmission.
A variety of cells, such as intraepithelial T lymphocytes
and Langerhans cells, are present in the skin and are capable
to generate local immune reactions. Branchelente et al. [9]
demonstrated that the local immune response in lesional skin
of naturally infected dogs included IFN-γ, TNF-α, and IL-4
expression. The increased expression of IL-4 was associated
with severe clinical signs and a high parasite burden in the
skin biopsies. More recently, Menezes-Souza et al. [12] anal-
ysed the expression of proinflammatory, anti-inflamatory,
and immunoregulatory cytokines as well as the levels of
transcription factors T-bet (associated with Th1 immune
response), GATA-3 (associated with Th2 immune response),
and FOXP3 (involved in the regulation of cytokine gene
transcription) in the skin without lesion of dogs naturally
infected. A mixed Th1/Th2 cytokine profile was observed in
asymptomatic dogs. Additionally, low levels of transcription
factors GATA-3 and FOXP3 were also correlated with the
absence of clinical signs. The data obtained indicate that
in asymptomatic infection or in cases with lower skin
parasitism, a mixed inflammatory and regulatory immune
response profile may be of major relevance for both the
maintenance of the clinical status of the dogs as well as for
parasite replication at low levels.
Fondevila et al. [32] and Papadogiannakis et al. [33]
investigated the cellular immunophenotyping and the num-
ber of amastigotes in the epidermis and dermis in dogs
with patent leishmaniasis. For these authors, alopecic and
sebaceous adenitis were associated with an effective local
immune response characterized by the activation of epider-
mal Langerhans cells, upregulation of MHC-II molecules
on keratinocytes, dermal infiltration by CD8+ and a lower
number of CD4+ cells, presence of CD21+ cells, and a
relatively low parasite burden. On the other hand, dogs with
generalized nodular disease mounted an impaired immune
response characterized by a low epidermal expression of
MHC-II molecules, small numbers of T cells in the dermal
infiltrate, and a high parasite burden [32]. Taking into
account data obtained in several studies, it would be
important to determine the immunophenotype associated
with the absence of parasites in the skin.
2.3. Lymph Nodes. Lymph nodes (LN) are widely accepted
to be the first relevant lymphoid tissues affected after
dissemination of the parasite from skin macrophages; thus,
the evaluation of their immune response to Leishmania
might help in determining the infection outcome. However,
the cellular immune responses developed in LN to L.
infantum are scarce. Giunchetti et al. [34] analysed the
immunophenotypic profile in popliteal LN from naturally
infected dogs and its relation with parasite burden in this
organ and skin. A significant increased number of T lympho-
cytes, particularly CD8+ cells, in addition to decreased levels
of CD21+ B cells and upregulation of MHC-II molecules
were the major LN immunophenotypic changes observed.
Interestingly, the highest number of CD8+ T cells was
observed in animals harbouring the highest skin parasitism.
According to the authors, LN CD8+ T cells may present a
distinct activation status during CanL, probably associated
with immunomodulatory or suppressor cell activity. In fact,
the immunomodulatory effect of these cells was recently
observed by Alexandre-Pires et al. [23] where that CD8+
subpopulation in LN from treated dogs was significantly
lower than in asymptomatic dogs. Moreover, CD4+ T-cell
subset in LN from both asymptomatic and treated dogs was
significantly higher than that in noninfected dogs. Together,
these findings suggested that lymphocyte activation in the
LNs with the expansion of CD4+ subpopulation may favour
the control of Leishmania infection through a local reduction
of parasite replication and/or parasite clearance while an
increase of the number of CD8+ cells seem to be related with
parasite persistence and immunomodulatory cell activity.
Regarding cytokine profile, Alves et al. [35] evaluated
its relation with parasite burden in prescapular LN from
naturally infected dogs and observed that the balance
of expression of IFN-γ, TNF-α, IL-10, and transforming
growth factor-beta (TGF-β) determines parasite load and
clinical expression. LN from asymptomatic dogs had higher
expression of proinflamatory cytokines and lower number of
parasites indicating that IFN-γ and TNF-α could play a role
in protection against disease while LN from symptomatic
dogs expressed more anti-inflamatory cytokines suggesting
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a role for IL-10 and TGF-β in disease progression. This
event is in agreement with the cytokine profile observed
by us in popliteal LN from dogs experimentally infected
where the balance between the percentage of IL-10 and
TNF-α expression (Table 1) could have been the responsible
not only for a lower parasite load in this tissue than in
others (skin, hepatic, and splenic), but also for the absence
of lymphadenomegaly or other clinical signs at the end of
the study in most of the infected dogs (only one dog had
popliteal adenomegaly).
All these data highlight that more studies focused on
specific immunological events in LN, namely, on cytokine
profile and CD8+ T and CD4+ subpopulations, should be
performed in order to determine if triggering an effective
immune response in this lymphoid tissue could avoid an
intense multiplication and consequent dissemination of the
parasite to other organs [35].
2.4. Liver. One of the most relevant organs involved in the
parasite-host interface during L. infantum infection is the
hepatic compartment. However, and as far as we are aware,
only one study quantified the cytokine production by the
liver of dogs infected and observed that the production
of IFN-γ, IL-10, and TGF-β1 was higher in those with
no clinical signs [36]. Our results on experimental CanL
correlated these findings as liver cells of the infected animals
also expressed those cytokines as well as iNOS (Table 1).
On the other hand, there was no expression of TNF-α and
IL-4. The presence of interlobular granulomas of variable
severity in infected dogs could be a reaction of the organism
to parasitism in an attempt to control the multiplication
of the parasites [37]. The presence of hepatic granulomas
was also correlated with subclinical human VL [38]. In
addition, Stanley and Engwerda [39] suggested that apart
from IFN-γ responsible for the generation of leishmanicidal
mechanisms, TNF-α is also involved in hepatic granuloma
formation and contributes to the resolution of local infection
in the murine model. Thus, the no expression of TNF-α by
the hepatic cells of our experimentally infected dogs could
have been associated with the high parasitism observed [2].
As mentioned above, data regarding cytokine profile
are also quite limited highlighting the necessity to perform
more studies in order to improve our knowledge concerning
the immune response developed in liver during visceral
Leishmania infection.
2.5. Spleen. CanL is associated with splenic architecture dis-
ruption, which is characterized by disorganization of normal
lymphoid tissue, loss of normal spleen leukocyte diversity
via replacement of leukocytes by plasma cells, and eventual
atrophy of the lymphoid tissue [40]. Thus, whilst the spleen is
responsible for the major immune response in leishmaniasis,
the present knowledge of the cytokines and leukocytes that
participate in its immune response is very limited since few
studies were performed. RNA expression levels of a wide
range of cytokines (IFN-γ, TNF-α, IL-4, IL-5, IL-10, IL-12,
IL-18, and TGF-β), transcription factors (T-bet and GATA3),
and chemokines (IP-10, RANTES, MIP-1α, MCP-1) were
evaluated in the spleen from naturally and experimentally
infected dogs [10, 41]. A positive correlation between the
expression of IL-10 by splenocytes with both increased
parasite load and progression of the disease was observed
in naturally infected dogs [41]. According to Santana et al.
[42], the production of IL-10 within splenic granulomas
may provide immunological conditions for the survival and
growth of the parasite. On the opposite, Strauss-Ayali et al.
[10] did not find any change in the expression of IL-10 by
splenocytes throughout experimental infection with 8.6 ×
108 L. infantum amastigotes, even in animals with a high
parasite load. Similar result was obtained by Corrêa et al. [36]
where no differences were found in the production of IL-10
by spleen extracts between symptomatic and asymptomatic
naturally infected dogs. On the other hand, Strauss-Ayali et
al. [10] suggested that the early increase of IL-4 might have
a role in the persistence of parasites in the presence of high
IFN-γ expression. An association between high levels of IFN-
γ and chemokines expression and splenic parasitism with
a worst disease prognostic was also observed [10, 36, 41].
Interestingly, in our experimental infected dogs, IFN-γ was
only expressed by the tissues with high parasite load, namely,
spleen, bone marrow, and liver (Table 1), suggesting that
the presence of this cytokine is not synonymous of parasite
clearance. One possible explanation for the association
between IFN-γ presence and the high parasite load could
be that new parasite generations are constantly being seeded
from other infected tissues stimulating its expression [10].
Furthermore, the levels of IFN-γ and chemokines expression
significantly decreased after treatment, reflecting a reduced
recruitment of immune cells into the spleen due to the
minimal amount of parasites remaining in the organ. It is
important to mention that at this moment the source of
such IFN-γ is not known, and probably it is not produced
by T cells, since symptomatic dogs show T-cell depletion
in the spleen and a specific immunosuppression against the
parasite.
The elevated levels of the tested chemokines observed by
Strauss-Ayali et al. [10] were suggestive of an accumulation
of infiltrating monocytes attracted by MIP1-α and MCP-1, as
well as of CD4+Th1 and CD8+ cells which could have been
recruited by IP-10. In agreement with these data, Guerra et
al. [19] observed an increased frequency of CD8+ T cells in
the spleen with low parasite load.
Nevertheless, in the few studies performed up to now,
none of the Th2 [36], Th1/Treg [41], or Th1/Th2 [10]
cytokine immune responses neither the chemokine nor
phenotypic cell profiles obtained were able to eliminate the
parasite locally.
2.6. Bone Marrow. Progression of Leishmania infection has
been related with a granulomatous inflammation in bone
marrow accompanied by an increased percentage of lym-
phocytes and plasma cells, erythroid and megakaryocytic
hypoplasia, and/or dysplasia and erythrophagocytosis [4].
According to Manzillo et al. [43], megakaryocytic and
erythroid dysplasia were probably related to an increased
number of bone marrow macrophages producing high levels
of TNF-α and IFN-γ. In agreement with this hypothesis,
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Quinnell et al. [44] observed an increased accumulation of
these cytokines in bone marrow of naturally infected dogs
with and without clinical signs. These authors also detected a
significant positive correlation between disease severity and
IL-4. However, this cytokine was not expressed by the bone
marrow cells of dogs experimentally infected six months after
infection (Table 1). Instead, iNOS and a mixed pattern of
proinflamatory (TNF-α) and regulatory (TGF-β and IL-10)
cytokines were detected in those asymptomatic dogs. Thus,
one of the reasons for the asymptomatic evolution of the
infection observed in those dogs despite the high parasite
load in bone marrow, liver, and spleen could have been
related with the no expression IL-4 by these organs.
In a study on bone marrow leukocyte subpopulations in
naturally infected dogs with and without clinical signs of
CanL and after being treated for leishmaniasis, Alexandre-
Pires et al. [23] observed that symptomatic and asymp-
tomatic animals exhibited a significant increase of MHC-II
expression in bone marrow lymphocytes probably reflecting
the presentation of Leishmania antigens. Moreover, treated
animals also showed increased expression of MHC-II mono-
cytes pointing out to elevated levels of antigenic presentation
activity, possibly due to the availability of parasite antigens
as a consequence of treatment. No differences in CD8+
and CD4+ T-cell populations were observed between the
three studied groups allowing hypothesizing that the control
of infection in the bone marrow is not related with the
expansion of these cells.
3. Conclusions
The cytokines and phenotypic cell profiles that participate
in immune responses in different compartments where the
parasite replicates seem to have variable effects on local
parasite control, highlighting the complexity of the cellular
immune response developed by the dog to L. infantum
infection. Moreover, these studies have disclosed interesting
facets of the immune response, even contradicting some
dogmas such as the role of IFN-γ in parasite clearance.
Furthermore, this paper also stressed that the knowledge
of the immune responses in some lymphoid compartments
(liver, lymph node, and spleen) is very limited.
Since the presence and intensity of parasites in blood
in CanL are normally low and transient, the generation of
immunological data in this tissue might not be an accurate
reflection of immune responses that occur in the body
compartments where a high parasitism is normally observed.
On the other hand, could the immune response in PB
be the result of the immune responses developed in the
different organs and thus be used as a prognosis marker?
Or could local immune response developed in spleen, the
major lymphoid organ involved in parasite-host interaction,
be used to predict the evolution of infection? In fact, here, the
invasive method of sampling must be considered.
Future integrated studies are needed in order to clar-
ify the association between the trafficking of various cell
subpopulations, cytokine, and chemokine gradients in asso-
ciation with the immune responses and parasite loads in
the different visceral and peripheral tissues developed at the
same time and in the same animal in order to improve the
knowledge of local and systemic immune responses in CanL.
The effective immune response able to control the parasite
must be evaluated in animals with no clinical signs and with
very low parasite burden since only these animals can be
considered immune competent/resistant to clinical disease.
In addition, the identification of specific cell subpopulations
that are involved in disease control in different organs
will allow control strategies namely, the development of
efficacious therapeutic and prophylactic tools.
Conflict of Interests
All authors declare that they have no conflict of interests
concerning the work reported in this paper.
Ethical Guidelines
The study on Leishmania infantum experimental infected
dogs followed the International Guiding Principles for
Biomedical Research Involving Animals and the guidelines
of the Portuguese Legislation (Lei n◦92/95, 12.9) and was
approved by the Ethics Committee of the Instituto de Higiene
e Medicina Tropical, Universidade Nova de Lisboa.
Acknowledgments
The authers M. Nunes and N. Rolão for technical support in
experimental CanL. C. Maia (SFRH/BPD/44082/2008) holds
a fellowship from Fundação para a Ciência e Tecnologia,
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